Clinical Trial

AI Model for Cervical Cancer Detection From Colposcopy Images

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 16, 2024 (before its estimated January 11, 2025 completion). Its status may not reflect the trial's current state.
Summary
Cervical cancer is a significant health issue, particularly in low-income countries, where late diagnosis and limited access to screenings contribute to high mortality rates. This study aims to develop and evaluate an artificial intelligence (AI) model to analyze colposcopic images for detecting cervical cancer more accurately and efficiently. Colposcopy, a procedure used to examine the cervix for signs of cancer, relies heavily on doctors' expertise, leading to inconsistent results. The current gold standard, colposcopy-directed biopsy, is invasive and can cause complications. The hypothesis is that an AI model can outperform traditional methods in identifying cervical abnormalities, providing a reliable and scalable solution for early detection, especially in underserved areas. By automating the analysis process, the AI model aims to reduce reliance on trained personnel, making cervical cancer screening more accessible and improving early diagnosis and treatment outcomes. The study will create a diverse dataset of colposcopy images from various sources and develop the AI model. The model's performance will be validated in clinical settings, assessing its accuracy in classifying cancer stages and identifying transformation zones. The impact on early detection, patient outcomes, and model usability will be evaluated, as well as its generalizability across different healthcare environments. The goal is to enhance the accuracy and efficiency of cervical cancer screening, ultimately reducing mortality rates and improving patient care.
Trial Details
NCT Number NCT06644248
Lead Sponsor Bangladesh University of Engineering and Technology
Conditions Uterine Cervical Neoplasms
Enrollment 500 participants
Start Date 2024-01-11
Primary Completion 2025-01-11 (estimated)
Study Completion 2025-02-11 (estimated)
Updated on ClinicalTrials.gov 2024-10-16